4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-057007
Chief Business Development Off sold 6,772 shares at an average $45.58 ($308,642)
- Chief Business Development Off acquired 6,772 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
BENZENO SHARON · Chief Business Development Off
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 1 in the form | +2,605 | $6.55 | $17,063 | 2,605 | D |
| 2020-11-02 | Exercise or conversion : show line 2 in the form | +2,604 | $6.55 | $17,056 | 5,209 | D |
| 2020-11-02 | Exercise or conversion : show line 3 in the form | +1,563 | $7.27 | $11,363 | 6,772 | D |
| 2020-11-02 | Sale : show line 4 in the form | −5,698 | $45.47 | $259,088 | 1,074 | D |
| 2020-11-02 | Sale : show line 5 in the form | −1,074 | $46.14 | $49,554 | 0 | D |
| Open-market sales · 6,772 sh · avg $45.58 · $308,642 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-02 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −2,605 | 31,250 | D |
| 2020-11-02 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −2,604 | 59,896 | D |
| 2020-11-02 | Exercise or conversion : show line 8 in the form Common Stock (Right to Buy) | −1,563 | 40,625 | D |
Loading xslF345X03/doc4.xml…